Coronavirus Vaccine Effort That Hopes To Start Early Production



SCIENTISTS HOPING TO START PRODUCTION EVEN BEFORE IT’S APPROVED





                               START PRODUCTION EVEN BEFORE IT’S APPROVED. HERE’S ANNE THOMPSON. BEFORE IT’S APPROVED. HERE’S ANNE THOMPSON. Reporter: ARE ITS HERE’S ANNE THOMPSON. Reporter: ARE ITS DISTINCTIVE SPIKES A Reporter: ARE ITS DISTINCTIVE SPIKES A KEY TO A VACCINE FOR DISTINCTIVE SPIKES A KEY TO A VACCINE FOR CORONAVIRUS? KEY TO A VACCINE FOR CORONAVIRUS?


 A JOINT PROJECT BY THE CORONAVIRUS?


 A JOINT PROJECT BY THE FEDERAL GOVERNMENT AND A JOINT PROJECT BY THE FEDERAL GOVERNMENT AND JOHNSON & JOHNSON IS FEDERAL GOVERNMENT AND JOHNSON & JOHNSON IS BETTING A BILLION JOHNSON & 


JOHNSON IS BETTING A BILLION DOLLARS IT IS. BETTING A BILLION DOLLARS IT IS.



 WE’VE GOT A DOLLARS IT IS. WE’VE GOT A CANDIDATE THAT HAS A WE’VE GOT A CANDIDATE THAT HAS A HIGH DEGREE OF CANDIDATE THAT HAS A HIGH DEGREE OF PROBABILITY OF BEING HIGH DEGREE OF PROBABILITY OF BEING SUCCESSFUL AGAINST THE PROBABILITY OF BEING SUCCESSFUL AGAINST THE COVID-19 VIRUS. 

SUCCESSFUL AGAINST THE COVID-19 VIRUS. 

Reporter: 

                  THE COVID-19 VIRUS.

Reporter:

                 THE DOCTOR HELPED DEVELOP 


Reporter:

                 THE DOCTOR HELPED DEVELOP THE POTENTIAL VACCINE DOCTOR HELPED DEVELOP THE POTENTIAL VACCINE IN HIS BOSTON LAB. THE POTENTIAL VACCINE IN HIS BOSTON LAB. USING A DISABLED IN HIS BOSTON LAB. 



USING A DISABLED COMMON COLD VIRUS USING A DISABLED COMMON COLD VIRUS PROVEN SAFE ON WORK ON COMMON COLD VIRUS PROVEN SAFE ON WORK ON VACCINES FOR HIV, AIDS PROVEN SAFE ON WORK ON VACCINES FOR HIV, AIDS AND EBOLA SCIENTISTS VACCINES FOR HIV, AIDS AND EBOLA SCIENTISTS INSERT THE CORONAVIRUS AND EBOLA SCIENTISTS INSERT THE CORONAVIRUS SPIKES AND THEN INJECT INSERT THE CORONAVIRUS SPIKES AND THEN INJECT IT. SPIKES AND THEN INJECT IT.


THE SPIKE PROTEIN IT. 


THE SPIKE PROTEIN IS SYNTHESIZE ASKED THE SPIKE PROTEIN IS SYNTHESIZE ASKED THE BODY MAKES AN IS SYNTHESIZE ASKED THE BODY MAKES AN IMMUNE RESPONSE TO IT, THE BODY MAKES AN IMMUNE RESPONSE TO IT, AND THAT IS THE IMMUNE RESPONSE TO IT, AND THAT IS THE VACCINE. AND THAT IS THE VACCINE. SUCCESSFULLY TESTED ON VACCINE. 



 SUCCESSFULLY TESTED ON ANIMALS 

HUMAN TRIALS WILL START IN ANIMALS HUMAN TRIALS WILL START IN SEPTEMBER. WILL START IN SEPTEMBER. WHAT WE NEED IS TO SEPTEMBER. WHAT WE NEED IS TO MAKE VACCINES FOR A WHAT WE NEED IS TO MAKE VACCINES FOR A BILLION PEOPLE, AND WE MAKE VACCINES FOR A BILLION PEOPLE, AND WE NEED TO MAKE THAT AS BILLION PEOPLE, AND WE NEED TO MAKE THAT AS QUICKLY AS POSSIBLE.


CREATE QUICKLY AS POSSIBLE


 NEED TO MAKE THAT AS QUICKLY AS POSSIBLE. THE RACE TO CREATE QUICKLY AS POSSIBLE. THE RACE TO CREATE A VACCINE TOOK OFF THE RACE TO CREATE A VACCINE TOOK OFF JANUARY 10th WHEN A VACCINE TOOK OFF JANUARY 10th WHEN CHINESE SCIENTISTS JANUARY 10th WHEN CHINESE SCIENTISTS RELEASED THE VIRUS’S CHINESE SCIENTISTS RELEASED THE VIRUS’S GENETIC SEQUENCE. RELEASED THE VIRUS’S GENETIC SEQUENCE. A SERIES OF LETTERS GENETIC SEQUENCE.


 A SERIES OF LETTERS 

REVEALING THE A SERIES OF LETTERS REVEALING THE BLUEPRINT USED BY REVEALING THE BLUEPRINT USED BY RESEARCHERS ALL OVER BLUEPRINT USED BY RESEARCHERS ALL OVER THE WORLD TO DESIGN RESEARCHERS ALL OVER THE WORLD TO DESIGN MORE THAN 50 VACCINE THE WORLD TO DESIGN MORE THAN 50 VACCINE CANDIDATES. MORE THAN 50 VACCINE CANDIDATES. JANUARY 10th, CANDIDATES. JANUARY 10th, AROUND 11:00 P.M., JANUARY 10th, AROUND 11:00 P.M., THAT’S WHEN WE AROUND 11:00 P.M., THAT’S WHEN WE STARTED. THAT’S WHEN WE STARTED. Reporter: LONG STARTED. Reporter: LONG BEFORE GOVERNMENTS A Reporter: LONG BEFORE GOVERNMENTS A STARTING PAYING BEFORE GOVERNMENTS A STARTING PAYING ATTENTION. STARTING PAYING ATTENTION. STARTING NEXT YEAR ATTENTION.



 STARTING NEXT YEAR WE’LL BE ABLE TO START STARTING NEXT YEAR WE’LL BE ABLE TO START DELIVERING FROM OUR WE’LL BE ABLE TO START DELIVERING FROM OUR MANUFACTURING PLANT. DELIVERING FROM OUR MANUFACTURING PLANT. 


Reporter:

                   MANUFACTURING PLANT.

 Reporter:

                  DRAMATICALLY SHRINKING Reporter: DRAMATICALLY SHRINKING DEVELOPMENT TIME FROM DRAMATICALLY SHRINKING DEVELOPMENT TIME FROM 5 TO 7 YEARS TO JUST DEVELOPMENT TIME FROM 5 TO 7 YEARS TO JUST 1225018 MONTHS. 5 TO 7 YEARS TO JUST 1225018 MONTHS. CAN WE TRUST A 1225018 MONTHS. 




CAN WE TRUST A VACCINE THAT HAS BEEN CAN WE TRUST A VACCINE THAT HAS BEEN FAST TRACKED IN. VACCINE THAT HAS BEEN FAST TRACKED IN.




 THAT’S THE MOST FAST TRACKED IN. 


THAT’S THE MOST IMPORTANT QUESTION, THAT’S THE MOST IMPORTANT QUESTION, AND I THINK WHAT’S IMPORTANT QUESTION, AND I THINK WHAT’S IMPORTANT FOR PEOPLE AND I THINK WHAT’S IMPORTANT FOR PEOPLE TO UNDERSTAND IS THAT IMPORTANT FOR PEOPLE TO UNDERSTAND IS THAT WE CAN GO FAST BUT WE TO UNDERSTAND IS THAT WE CAN GO FAST BUT WE CAN’T CUT CORNERS AND WE CAN GO FAST BUT WE CAN’T CUT CORNERS AND WE’RE NOT GOING TO CUT CAN’T CUT CORNERS AND WE’RE NOT GOING TO CUT CORNERS. WE’RE NOT GOING TO CUT CORNERS. 






WE CAN FOLLOW ALL THE CORNERS. WE CAN FOLLOW ALL THE GUIDELINES, BUT BY WE CAN FOLLOW ALL THE GUIDELINES, BUT BY DOING THEM IN PARALLEL GUIDELINES, BUT BY DOING THEM IN PARALLEL AND NOT IN SEQUENCE WE DOING THEM IN PARALLEL AND NOT IN SEQUENCE WE CAN SHORTEN THOSE TIME

Post a Comment

أحدث أقدم